✦ LIBER ✦

Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia

✍ Scribed by Giuseppe Longo; Giovanna Gandini; Leonardo Ferrara; Umberto Torelli; Giovanni Emilia

Book ID: 114792232
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 185 KB
Volume: 59
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1997.tb00737.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine-associated autoimmune hemoly

Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia

✍ Hiroko Nishida; Tadashi Murase; Hironori Ueno; Jae Wong Park; Takahiro Yano; Yas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Fatal intravascular autoimmune hemolytic

Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia

✍ G. Tertian; J. Cartron; C. Bayle; A. Rudent; T. Lambert; G. Tchernia 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 99 KB

Fludarabine-related hemolytic anemia in

✍ Taha, Hesham M.; Narasihman, Parths; Venkatesh, Latha; Cawley, Margrete; Kaplan, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 13 KB

Mechanism of autoimmune hemolytic anemia

Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia

✍ Zev M. Sthoeger; Dr. Dalia Sthoeger; Mordechai Shtalrid; Erica Sigler; David Gel 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Severe autoimmune hemolytic anemia in a

Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment

✍ S. Tosti; R. Caruso; F. D'Adamo; A. Picardi; M. Ali Ege; G. Girelli; F. R. Mauro 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 166 KB

Rituximab therapy for chronic lymphocyti

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia

✍ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W